App-based program to support wellness and engagement during recovery
Mobile Platform for Optimizing Wellness and Engagement in Recovery
This pilot will test whether a smartphone app that uses digital contingency management (rewards) helps Michigan Medicaid patients on buprenorphine or methadone who also have alcohol use disorder stay engaged in recovery and reduce substance use.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 19 Years to 63 Years |
| Sex | All |
| Sponsor | University of Michigan Academic / other |
| Locations | 1 site (Ann Arbor, Michigan) |
| Trial ID | NCT07178990 on ClinicalTrials.gov |
What this trial studies
This pilot targets people with co-occurring opioid and alcohol use disorders who are enrolled in Michigan Medicaid and receiving opioid agonist treatment. Participants must have started buprenorphine or methadone, report alcohol use disorder, have a working smartphone and internet, and a reliable mailing address for remote salivary testing. Enrollees are assigned to either a digital contingency management intervention arm or a digital wellness arm and complete app-based activities plus remote biological monitoring. The study measures feasibility and acceptability of the digital approach and gathers information to plan broader implementation if successful.
Who should consider this trial
Good fit: Ideal candidates are Michigan Medicaid enrollees who have initiated buprenorphine or methadone, report alcohol use disorder, can read English, have a working smartphone and reliable mailing address, and can provide informed consent.
Not a fit: Patients unlikely to benefit include people not enrolled in Michigan Medicaid, dual-eligible Medicare beneficiaries aged 65 or older, those without smartphone or internet access, people with substantial cognitive impairment or who cannot consent, and non-English speakers.
Why it matters
Potential benefit: If successful, the app could provide a scalable way to increase recovery engagement and reduce opioid and alcohol use by delivering remote incentives and support.
How similar studies have performed: Contingency management has established effectiveness for substance use disorders and digital CM has shown promise, but using app-based CM specifically for co-occurring opioid and alcohol use among Medicaid patients is relatively novel and being piloted.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must be enrolled in the Michigan Medicaid program * Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone * Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening * Participants must have regular access to a working smartphone and internet connection. * Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests). Exclusion Criteria: * Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group * Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency * Individuals with substantial cognitive impairment that would interfere with study participation * Individuals unable to read or understand English * Individuals experiencing active suicidality or psychosis. * Individuals with a planned admission to residential treatment or incarceration during the study period.
Where this trial is running
Ann Arbor, Michigan
- University of Michigan — Ann Arbor, Michigan, United States (Recruiting)
Study contacts
- Principal investigator: Lara Coughlin, PhD — University of Michigan
- Study coordinator: Haley Stevens
- Email: hsteve@med.umich.edu
- Phone: 734-764-9910
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.